International Journal of Innovative Research in Engineering and Management
Year: 2018, Volume: 5, Issue: 1
First page : ( 35) Last page : ( 41)
Online ISSN : 2350-0557.
DOI: 10.21276/ijirem.2018.5.1.8 | DOI URL: https://doi.org/10.21276/ijirem.2018.5.1.8 Crossref
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (http://creativecommons.org/licenses/by/4.0)
Article Tools: Print the Abstract | Indexing metadata | How to cite item | Email this article | Post a Comment
Dr.Oye, N. D. , Vivian, Nathaniel, Jemimah, Nathaniel
This research is based on the order for consumers to make effective decisions when using drugs, there is the need to make certain information available. The use of drug verification system to provide information on registered pharmaceutical drugs will be of immense help to the country and the world. With the help of this system, the user can search if a prescribed drug is registered. This system is a web-based application developed using Hypertext Pre-processor (PHP) and MYSQL database, the methodology used in the implementation of the system is Vshaped model of System Development Life Cycle (SDLC). This system integrates with registered drugs and their respective details from National Agency for Food and Drug Administration and Control (NAFDAC) and the software developed for the implementation of this research can be used by any drug enforcement agency other than NAFDAC. It also provides solution to help in the fight against counterfeit drugs and majorly unregistered drugs by allowing users to verify the authenticity of the drugs and to report otherwise.
(1) Akinyandenu, O. (2013, Semtember 29). Counterfeit drugs in Nigeria: A threat to public health. African Journal of Pharmacy and Pharmacology, 7(36), 2572-2576.
(2) Akunyili, D. (2005, march 10). "counterfeit and substandard drugs, nigeria's experience: implications, challenges, actions and recommendations". meeting for key interest groups on health.
(3) Akunyili, D. N. (2005). “counterfeit drugs and pharmacovigilance". the 10th pharmacovigilance, (pp. 1-64). sweden.
(4) Assembly and the Working Groups. (2006-2010). IMPACT! International Medical Products Ant-Counterfeiting Taskforce. (D. D. Giorgio, M. Gramazio, G. Derossi, E. Cesta, M. Chiavoni, & G. Falcioni, Eds.) Italy: Anderson Borgomanero (NO).
(5) Bint Muhammad, N. A. (2010). drug management system. universiti malaysia pahang, computer systems and software engineering.
(6) Chambliss, W. G., Carroll, W. A., Kennedy, D. B., Levine, D. P., Moné, M. A., Ried, D. L., . . . Yelvigi, M. (2012, June 3). role of the pharmacist in preventing distribution of counterfeit medications. preventing distribution of counterfeit medications, 2(52), 195-199.
(7) Chinwendu, O. (2008, Semptember 12). the fight against fake drugs by nafdac in nigeria. 44th international course in health development (ichd), pp. 1-67.
(8) (2013). Countering the Problem of Falsified and Substandard Drugs. institute of medicine of the national academies, national academy of sciences. 500 fifth street, nw washington, dc 20001: national academy of sciences.
(9) Federal Ministry of Health. (2012). national drug distribution guidelines (2 ed.).
(10) Fenoff, R. S., & Wilson, J. M. (2009, October). africa’s counterfeit pharmaceutical epidemic. the road ahead, pp. 1- 20.
(11) Howard, D. (2010, August). Silent Epidemic: protecting the safety and security of drugs. retrieved november 19, 2016,from pharmaceutical outsourcing: http://www.pharmoutsourcing.com
(12) Kester, Q.-A., Owusu, P. A., & Hatsu, S. (2015). pharmaceutical verification and information system for authentication of registered drugs. international journal of emerging research in management &technology, 4(3), 1-15.
(13) National Agency for Food and Drug Administration and Control. (2013). (smartaddons.com) retrieved 10 29, 2016, from www.nafdac.gov.ng: http://www.nafdac.gov.ng
(14) National Assembly of Boards of Pharmacy. (2011). retrieved november 19, 2016, from verified internet pharmacy practice sites (vipps): http://www.nabp.net
(15) Onuiri, E. E., Oyebanji, I. G., Fayehun, S. A., & Chukwujioke, S. D. (2016). online pharmaceutical management system. european scientific journal, 12(12), 139-156.
(16) Onyebuchi, O. B. (2015, December 17). national drug distribution in nigeria; implications for the goals of national drug policy. european journal of pharmaceutical and medical research, 1(3), 1-4.
(17) Pavel, J. (2004). System Development Life Cycle. Retrieved 11 19, 2016, from www.dk.upce.cz: http://dk.upce.cz
(18) P-ORG. (2012). Retrieved 0ctober 29, 2016, from www.proud-to-be.org: http://www.proud-tobe.org/eng/statistics
(19) Report, Counterfeit Pharmaceutical Inter-agency Working Group. (2011, March). counterfeit pharmaceutical interagency working group report to the vice president of the united states and to congress. retrieved 11 19, 2016, from www.whitehouse.gov: http://www.whitehouse.gov
(20) Sommerville, I. (2011). Software Engineering (9 ed.). (j. holcom, ed.) united states of america: pearson education, inc.
(21) Stricker, B., & Psaty, B. M. (2006, November 1). Detection, Verification, and quantification of adverse drug reactions. Retrieved November 20, 2016, from bmj.com: http://www.bmj.com
(22) Wright, E. (2006, December). Counterfeit drugs: definitions; origins and legislation. (177), 22-24. Retrieved from www.euralex.co.uk.
(23) Ziance, R. J. (2008, June). Roles for Pharmacy in Combatting Counterfeit Drugs. American Pharmacist Associasion, 6(14), 55-57.
Department of Computer Science, MAUTECH Yola- Nigeria, +2347037460352 oyenath@yahoo.co.uk
No. of Downloads: 16 | No. of Views: 1185
Preet Bhutani, Chandra Sekhar Dash.
August 2024 - Vol 11, Issue 4
Tushar Maurya, Saurav Kumar Singh, Vikram Thakur, Sachin Chawla.
June 2024 - Vol 11, Issue 3
Sangeeta Devi, Munish Saran, Rajan Kumar Yadav, Pranjal Maurya, Upendra Nath Tripathi.
June 2024 - Vol 11, Issue 3